{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T18:44:57Z","timestamp":1773168297822,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005565","name":"Janssen Biotech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000948","name":"Pfizer Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000948","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000555","name":"British Microcirculation Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000555","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.semarthrit.2020.11.007","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T17:13:45Z","timestamp":1608225225000},"page":"101-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["A systematic review of the infectious complications of colchicine and the use of colchicine to treat infections"],"prefix":"10.1016","volume":"51","author":[{"given":"Timothy","family":"McEwan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip C","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.semarthrit.2020.11.007_bib0001","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.amjmed.2014.12.010","article-title":"Colchicine: old and new","volume":"128","author":"Slobodnick","year":"2015","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2020.11.007_bib0002","doi-asserted-by":"crossref","DOI":"10.1007\/s40495-020-00225-6","article-title":"Colchicine in COVID-19: an Old Drug, New Use","volume":"6","author":"Schlesinger","year":"2020","journal-title":"Curr Pharmacol Rep"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.11.007_bib0003","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Colchicine\u2013Update on mechanisms of action and therapeutic uses","volume":"45","author":"Leung","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.semarthrit.2020.11.007_bib0004","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1128\/JVI.77.7.4401-4408.2003","article-title":"Cytoskeletal requirements for hepatitis C virus (HCV) RNA synthesis in the HCV replicon cell culture system","volume":"77","author":"Bost","year":"2003","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.11.007_bib0005","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/cmdc.201800641","article-title":"Synthesis, biological evaluation, and molecular docking of combretastatin and colchicine derivatives and their hCE1-activated prodrugs as antiviral agents","volume":"14","author":"Richter","year":"2019","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.11.007_bib0006","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0166-0934(92)90162-7","article-title":"Colchicine treatment in the preparation of varicella-zoster virus inocula","volume":"36","author":"Cole","year":"1992","journal-title":"J Virol Methods"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.11.007_bib0007","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13075-020-2120-7","article-title":"Adverse events during oral colchicine use: a systematic review and meta-analysis of randomised controlled trials","volume":"22","author":"Stewart","year":"2020","journal-title":"Arthrit Res Therapy"},{"key":"10.1016\/j.semarthrit.2020.11.007_bib0008","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.11.007_bib0009","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1002\/cncr.22198","article-title":"Colchicine delays the development of hepatocellular carcinoma in patients with hepatitis virus-related liver cirrhosis","volume":"107","author":"Arrieta","year":"2006","journal-title":"Cancer"},{"issue":"4 SUPPL. 1","key":"10.1016\/j.semarthrit.2020.11.007_bib0010","article-title":"Ribavirin maintenance treatment reduces portal pressure in hepatitis C virus cirrhosis: a randomized open-label trial of ribavirin versus colchicine","volume":"58","author":"Albillos","year":"2013","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.semarthrit.2020.11.007_bib0011","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1046\/j.1365-2036.2000.00857.x","article-title":"Unfavourable effects of colchicine in combination with interferon-alpha in the treatment of chronic hepatitis C","volume":"14","author":"Angelico","year":"2000","journal-title":"Aliment Pharmacol Therapeut"},{"issue":"12","key":"10.1016\/j.semarthrit.2020.11.007_bib0012","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1111\/j.1572-0241.2001.05349.x","article-title":"Preliminary results of a two-center trial with colchicine for the treatment of chronic hepatitis B","volume":"96","author":"Floreani","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.11.007_bib0013","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1046\/j.1365-2036.1996.98270000.x","article-title":"A prospective randomized trial of colchicine in prevention of liver cirrhosis in chronic hepatitis B patients","volume":"10","author":"Lin","year":"1996","journal-title":"Aliment Pharmacol Therapeut"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.11.007_bib0014","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S0168-8278(94)80252-1","article-title":"A double-blind randomized controlled trial of colchicine in patients with hepatitis B virus-related postnecrotic cirrhosis","volume":"21","author":"Wang","year":"1994","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.11.007_bib0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.13136","article-title":"Effect of colchicine vs standard care on cardiac and inflammatory biomarkers and clinical outcomes in patients hospitalized with coronavirus disease 2019: the GRECCO-19 randomized clinical trial","volume":"3","author":"Deftereos","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"10","key":"10.1016\/j.semarthrit.2020.11.007_bib0016","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1136\/annrheumdis-2020-217712","article-title":"Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome","volume":"79","author":"Scarsi","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.semarthrit.2020.11.007_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9092961","article-title":"Colchicine to weather the cytokine storm in hospitalized patients with COVID-19","volume":"9","author":"Brunetti","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.semarthrit.2020.11.007_bib0018","first-page":"217","article-title":"Treating COVID-19 with colchicine in community healthcare setting","author":"Della-Torre","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.semarthrit.2020.11.007_bib0019","article-title":"A potential therapeutic tool against COVID-19. Experience of 5 patients","author":"Montealegre-G\u00f3mez","year":"2020","journal-title":"Reumatol Clin"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.11.007_bib0020","doi-asserted-by":"crossref","first-page":"350","DOI":"10.5830\/CVJA-2016-035","article-title":"A prospective investigation into the effect of colchicine on tuberculous pericarditis","volume":"27","author":"Liebenberg","year":"2016","journal-title":"Cardiovasc J Afr"},{"issue":"7","key":"10.1016\/j.semarthrit.2020.11.007_bib0021","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jama.1967.03130070073027","article-title":"Colchicine-Quinine Therapy for Acute Falciparum Malaria Acquired in Vietnam","volume":"201","author":"Reba","year":"1967","journal-title":"JAMA: J Am Med Assoc"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.11.007_bib0022","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0022-5347(17)61636-7","article-title":"The successful treatment of intraurethral condyloma acuminata with colchicine","volume":"105","author":"Gigax","year":"1971","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.11.007_bib0023","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/jid.1951.20","article-title":"Experimental treatment of verrucha vulgaris with locally injected colchicine","volume":"16","author":"Nelson","year":"1951","journal-title":"J Invest Dermatol"},{"issue":"12","key":"10.1016\/j.semarthrit.2020.11.007_bib0024","first-page":"1420","article-title":"Microtubule inhibition therapy by colchicine in severe myocarditis especially caused by epstein-barr and cytomegalovirus co-infection during a two-year period: A novel therapeutic approach","volume":"64","author":"Gultekin","year":"2014","journal-title":"J Pak Med Assoc"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.11.007_bib0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.5935\/0305-7518.19880025","article-title":"Comparison of colchicine and aspirin in the treatment of type 2 lepra reaction","volume":"59","author":"Kar","year":"1988","journal-title":"Leprosy Rev"},{"issue":"908","key":"10.1016\/j.semarthrit.2020.11.007_bib0026","article-title":"The association between usage of colchicine and pneumonia: a nationwide, population-based cohort study","volume":"10","author":"Tsai","year":"2019","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.11.007_bib0027","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-01588-5","article-title":"Risk of infections in patients with gout: A population-based cohort study","volume":"7","author":"Spaetgens","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.11.007_bib0028","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/annrheumdis-2017-211574","article-title":"Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: Results from FORTUNE-1, a prospective, multicentre randomised study","volume":"77","author":"Yamanaka","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.semarthrit.2020.11.007_bib0029","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1136\/ard.2010.144063","article-title":"Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: Results of a double-blind, randomised study","volume":"70","author":"Schlesinger","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.11.007_bib0030","first-page":"1938","article-title":"The role of colchicine in Helicobacter pylori prevalence and gastric mucosal changes in Behcet's disease","volume":"28","author":"Pata","year":"2001","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.11.007_bib0031","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3109\/s10165-009-0200-2","article-title":"Colchicine versus placebo in Behcet's disease: randomized, double-blind, controlled crossover trial","volume":"19","author":"Davatchi","year":"2009","journal-title":"Mod Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.11.007_bib0032","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1053\/joca.2002.0516","article-title":"A randomized controlled trial to evaluate the slow-acting symptom modifying effects of a regimen containing colchicine in a subset of patients with osteoarthritis of the knee","volume":"10","author":"Das","year":"2002","journal-title":"Osteoarthrit Cartil"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.11.007_bib0033","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.joca.2018.01.026","article-title":"Colchicine lack of effectiveness in symptom and inflammation modification in knee osteoarthritis (COLKOA): a randomized controlled trial","volume":"26","author":"Leung","year":"2018","journal-title":"Osteoarthrit Cartil"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.11.007_bib0034","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1183\/09031936.06.00032605","article-title":"Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis","volume":"28","author":"Antoniou","year":"2006","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.11.007_bib0035","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/ejcts\/ezx422","article-title":"Colchicine for Prevention of Perioperative Atrial Fibrillation in patients undergoing lung resection surgery: A pilot randomized controlled study","volume":"53","author":"Bessissow","year":"2018","journal-title":"Eur J Cardio-Thoracic Surg"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.11.007_bib0036","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.semarthrit.2016.08.011","article-title":"Moderating effects of immunosuppressive medications and risk factors for post-operative joint infection following total joint arthroplasty in patients with rheumatoid arthritis or osteoarthritis","volume":"46","author":"Salt","year":"2017","journal-title":"Semin Arthrit Rheumat"},{"issue":"7","key":"10.1016\/j.semarthrit.2020.11.007_bib0037","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1111\/dom.13702","article-title":"Effects of colchicine in adults with metabolic syndrome: a pilot randomized controlled trial","volume":"21","author":"Demidowich","year":"2019","journal-title":"Diabet Obes Metab"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.11.007_bib0038","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1053\/j.gastro.2005.01.057","article-title":"Colchicine treatment of alcoholic cirrhosis: a randomized, placebo-controlled clinical trial of patient survival","volume":"128","author":"Morgan","year":"2005","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.11.007_bib0039","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/IPC.0000000000000246","article-title":"Effect of colchicine on clostridium difficile infection incidence, recurrence, and severity","volume":"23","author":"Young-Xu","year":"2015","journal-title":"Infect Dis Clin Pract"},{"key":"10.1016\/j.semarthrit.2020.11.007_bib0040","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","author":"Nidorf","year":"2020","journal-title":"New Engl J Med"},{"issue":"26","key":"10.1016\/j.semarthrit.2020.11.007_bib0041","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"New Engl J Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.11.007_bib0042","first-page":"4","article-title":"Colchicine to reduce atrial fibrillation in the postoperative period of myocardial revascularization","volume":"107","author":"Zarpelon","year":"2016","journal-title":"Arquivos Brasileiros de Cardiologia"},{"issue":"7","key":"10.1016\/j.semarthrit.2020.11.007_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102566","article-title":"Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis","volume":"19","author":"Gendelman","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"9","key":"10.1016\/j.semarthrit.2020.11.007_bib0044","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s00296-020-04645-x","article-title":"Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic","volume":"40","author":"Haslak","year":"2020","journal-title":"Rheumatol Int"},{"issue":"11","key":"10.1016\/j.semarthrit.2020.11.007_bib0045","doi-asserted-by":"crossref","DOI":"10.1007\/s13205-019-1917-z","article-title":"Inhibition of respiratory syncytial virus replication and suppression of RSV-induced airway inflammation in neonatal rats by colchicine","volume":"9","author":"Lu","year":"2019","journal-title":"3 Biotech"},{"key":"10.1016\/j.semarthrit.2020.11.007_bib0046","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1743-422X-10-121","article-title":"Do viruses require the cytoskeleton?","volume":"10","author":"Matthews","year":"2013","journal-title":"Virol J"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.11.007_bib0047","article-title":"Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis","author":"Rambaldi","year":"2005","journal-title":"Cochr Database Syst Rev"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.11.007_bib0048","article-title":"Colchicine for pericarditis","volume":"2014","author":"Alabed","year":"2014","journal-title":"Cochr Database Syst Rev"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.11.007_bib0049","doi-asserted-by":"crossref","first-page":"O100","DOI":"10.1186\/1532-429X-18-S1-O100","article-title":"Myocarditis and colchicine: a new perspective from cardiac MRI","volume":"18","author":"Morgenstern","year":"2016","journal-title":"J Cardiovasc Magn Resonan"},{"key":"10.1016\/j.semarthrit.2020.11.007_bib0050","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijcard.2016.04.144","article-title":"Colchicine aggravates coxsackievirus B3 infection in mice","volume":"216","author":"Smilde","year":"2016","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.11.007_bib0051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0031182096008050","article-title":"A role for microtubules in Plasmodium falciparum merozoite invasion","volume":"114","author":"Bejon","year":"1997","journal-title":"Parasitology"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.11.007_bib0052","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2217\/17460913.2.4.409","article-title":"Microtubule inhibitors as a potential treatment for malaria","volume":"2","author":"Kappes","year":"2007","journal-title":"Fut Microbiol"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.11.007_bib0053","first-page":"156","article-title":"Changes in the seroepidemiological pattern of Helicobacter pylori infection over the last 10 years","volume":"15","author":"Ozden","year":"2004","journal-title":"Turk J Gastroenterol"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.11.007_bib0054","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0736-4679(00)00160-8","article-title":"Colchicine-induced bone marrow suppression: treatment with granulocyte colony-stimulating factor11Selected Topics: Toxicology is coordinated by Kenneth Kulig, MD, of Denver, Colorado","volume":"18","author":"Harris","year":"2000","journal-title":"J Emerg Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.11.007_bib0055","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jemermed.2016.08.019","article-title":"Evaluation of the colchicine poisoning cases in a pediatric intensive care unit: five year study","volume":"52","author":"Polat","year":"2017","journal-title":"J Emerg Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.11.007_bib0056","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0736-4679(02)00430-4","article-title":"Deaths associated with inappropriate intravenous colchicine administration","volume":"22","author":"Bonnel","year":"2002","journal-title":"J Emerg Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.11.007_bib0057","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1345\/aph.10184","article-title":"Probable colchicine-induced neutropenia not related to intentional overdose","volume":"35","author":"Dixon","year":"2001","journal-title":"Ann Pharmacother"},{"issue":"11","key":"10.1016\/j.semarthrit.2020.11.007_bib0058","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/phar.1125","article-title":"Assessment of the association between colchicine therapy and serious adverse events","volume":"32","author":"Todd","year":"2012","journal-title":"Pharmacotherapy"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017220302961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017220302961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:04:26Z","timestamp":1758733466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017220302961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0049017220302961"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.11.007","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of the infectious complications of colchicine and the use of colchicine to treat infections","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}